[HTML][HTML] Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C

AS Moura, RA Carmo, AL Teixeira… - Brazilian Journal of …, 2009 - SciELO Brasil
Hepatitis C is an important burden worldwide being an important cause of cirrhosis and liver
cancer in different parts of the world. Host immune response, especially T helper type 1 …

[HTML][HTML] T lymphocytes from chronic HCV-infected patients are primed for activation-induced apoptosis and express unique pro-apoptotic gene signature

BB Zhao, SJ Zheng, LL Gong, Y Wang, CF Chen… - PloS one, 2013 - journals.plos.org
Although extensive studies have demonstrated the functional impairment of antigen-specific
CD4+ and CD8+ T-cells during chronic hepatitis C virus (HCV) infection, the functional …

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV

K Falconer, G Askarieh, N Weis… - … journal of infectious …, 2010 - Taylor & Francis
The aim of this study was to investigate the utility of baseline plasma interferon-gamma
inducible protein-10 (IP-10) levels in human immunodeficiency virus (HIV)–hepatitis C virus …

[HTML][HTML] CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study

IC Lee, YH Huang, CW Su, YJ Wang, TI Huo, KC Lee… - PLoS …, 2013 - journals.plos.org
Background and Aims There is lack of a practical biomarker to predict sustained virological
response (SVR) in chronic hepatitis B (CHB) patients undergoing peginterferon alfa-2a …

[HTML][HTML] Association of interferon-gamma induced protein 10 promoter polymorphisms with the disease progression of hepatitis B virus infection in Chinese Han …

Z Xu, Y Liu, L Liu, X Li, S Bai, Y Rong, H Wang, Y Mao… - PLoS …, 2013 - journals.plos.org
Background and Aims Interferon-gamma induced protein 10 (IP-10) was suggested to be
involved in liver injury in viral hepatitis. This study aimed to investigate the impact of the …

CXC chemokine IP-10: a key actor in liver disease?

LJ Chen, J Lv, XY Wen, JQ Niu - Hepatology international, 2013 - Springer
Abstract Interferon-γ-inducible protein 10 (IP-10), or CXC motif chemokine (CXCL10), is a
small cytokine belonging to the non-ELR CXC chemokine family. By binding to its specific …

Significance of serum IP‐10/CXCL10 measurement in predicting post‐direct acting antiviral treatment liver function in patients with HCV‐decompensated liver …

R Katoh, S Maekawa, L Osawa… - Hepatology …, 2023 - Wiley Online Library
Background Recently, with the advent of sofosbuvir/velpatasvir therapy, sustained
virological response (SVR) can now be achieved even in patients with decompensated …

Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir

SB Willemse, L Jansen, A de Niet, MJ Sinnige… - Antiviral research, 2016 - Elsevier
Introduction Interferon-y–inducible protein-10 (IP-10), also called CXCL10, is produced by
different types of cells such as monocytes, neutrophils and hepatocytes. IP-10 functions as …

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden

K Büsch, J Waldenström, M Lagging… - Scandinavian Journal …, 2017 - Taylor & Francis
Purpose: The aim of this study was to estimate the prevalence of physician-diagnosed and
registered chronic hepatitis C (CHC), and to estimate the reported frequencies of Charlson …

[HTML][HTML] The CXCL9/10/11-CXCR3 axis as a predictor of COVID-19 progression: a prospective, case-control study

N Çelik, O Çelik, E Laloğlu, A Özkaya - Revista da Sociedade …, 2023 - SciELO Brasil
Background: This study examined the relationship between levels of the chemokines
CXCL9, CXCL10, CXCL11, and CXCR3 and mortality in patients with COVID-19.. Methods …